コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ), but not a GABAA receptor channel blocker (pentylenetetrazol).
2 increased sensitivity to the chemoconvulsant pentylenetetrazol.
4 lsant potencies of systemically administered pentylenetetrazol (30-50 mg/kg) and NMDA (50-100 mg/kg).
7 elevated seizure response to the convulsant pentylenetetrazol compared with sham mice, associated wi
9 study, we evaluated the effects of 15 daily pentylenetetrazol-induced convulsions in immature rats b
14 ed plus-maze and increased susceptibility to pentylenetetrazol-induced seizures were apparent 96 h (b
16 sant activity of systemic AMPA, kainate, and pentylenetetrazol is not mediated by GluK1 kainate recep
19 M and (2) disinhibiting the slice using 3 mM pentylenetetrazol or combined application of 10 microM g
20 ids displayed anticonvulsant activity in the pentylenetetrazol (PTZ) and maximal electroshock (MES) t
21 investigate behavioral seizure responses to pentylenetetrazol (PTZ) and to map the location of genes
22 tion are consistent with the decrease in the pentylenetetrazol (PTZ) seizure threshold which was prev
24 CIE treatment also increased the ability of pentylenetetrazol (PTZ) to inhibit GABA mediated 36Cl- i
25 ing seizure susceptibility to the convulsant pentylenetetrazol (PTZ), given via timed tail vein infus
26 muli: 2,2,2-trifluroethyl ether (flurothyl), pentylenetetrazol (PTZ), kainic acid, and high-decibel s
27 olecular consequences of seizures induced by pentylenetetrazol (PTZ), which is a widely used convulsa
29 nic seizures and less EEG activity following pentylenetetrazol (PTZ; 70 mg/kg, IP) administration tha
30 ncidence of tonic-clonic seizures induced by pentylenetetrazol (PTZ; 70 mg/kg, IP) administration.
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。